Neuroproteomics: Expression profiling of the brain's proteomes in health and disease

Neurochemical Research

Volumn 29, Issue 6, 2004, Pages 1317-1331

  Kim, Sandra I ^a   Voshol, Hans ^b   Van Oostrum, Jan ^b   Hastings, Terri G ^c   Cascio, Michael ^c   Glucksman, Marc J ^a,d  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Brain; Neurodegenerative; Neurome; Parkinson's disease; Proteome; Psychiatric

Indexed keywords

BRAIN PROTEIN; DIZOCILPINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PROTEOME;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CEREBROSPINAL FLUID; CINGULATE GYRUS; CORRELATION ANALYSIS; DNA FINGERPRINTING; ENTORHINAL CORTEX; FRONTAL CORTEX; HIGH THROUGHPUT SCREENING; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PARKINSON DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RESPIRATORY CHAIN; REVIEW; SCHIZOPHRENIA; SENILE PLAQUE; SENSORIMOTOR CORTEX; TEMPORAL CORTEX; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; BRAIN DISEASE; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; PATHOLOGY; REFERENCE VALUE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ALZHEIMER DISEASE; ANIMALS; BRAIN DISEASES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HUMANS; PARKINSON DISEASE; PROTEOME; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 3142724647     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000023618.35579.7c     Document Type: Review

References (105)

1. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R., Williams, K. L., and Humphery Smith, I. 1995. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090-1094.
2. International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
3. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., Gocayne, J. D., Amanatides, P., Ballew, R. M., Huson, D. H., Wortman, J. R., Zhang, Q., Kodira, C. D., Zheng, X. H., Chen, L., Skupski, M., Subramanian, G., Thomas, P. D., Zhang, J., Gabor Miklos, G. L., Nelson, C., Broder, S., Clark, A. G., Nadeau, J., McKusick, V. A., Zinder, N., Levine, A. J., Roberts, R. J., Simon, M., Slayman, C., Hunkapiller, M., Bolanos, R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., Abu-Threideh, J., Beasley, E., Biddick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswarana, I., Charlab, R., Chaturvedi, K., Deng, Z., Di Francesco, V., Dunn, P., Eilbeck, K., Evangelista, C., Gabrielian, A. E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T. J., Higgins, M. E., Ji, R. R., Ke, Z., Ketchum, K. A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G. V., Milshina, N., Moore, H. M., Naik, A. K., Narayan, V. A., Neelam, B., Nusskern, D., Rusch, D. B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., Yao, A., Ye, J., Zhan, M., Zhang, W., Zhang, H., Zhao, Q., Zheng, L., Zhong, F., Zhong, W., Zhu, S., Zhao, S., Gilbert, D., Baumhueter, S., Spier, G., Carter, C., Cravchik, A., Woodage, T., Ali, F., An, H., Awe, A., Baldwin, D., Baden, H., Barnstead, M., Barrow, I., Beeson, K., Busam, D., Carver, A., Center, A., Cheng, M. L., Curry, L., Danaher, S., Davenport, L., Desilets, R., Dietz, S., Dodson, K., Doup, L., Ferriera, S., Garg, N., Gluecksmann, A., Hart, B., Haynes, J., Haynes, C., Heiner, C., Hladun, S., Hostin, D., Houck, J., Howland, T., Ibegwam, C., Johnson, J., Kalush, F., Kline, L., Koduru, S., Love, A., Mann, F., May, D., McCawley, S., McIntosh, T., McMullen, I., Moy, M., Moy, L., Murphy, B., Nelson, K., Pfannkoch, C., Pratts, E., Puri, V., Qureshi, H., Reardon, M., Rodriguez, R., Rogers, Y. H., Romblad, D., Ruhfel, B., Scott, R., Sitter, C., Smallwood, M., Stewart, E., Strong, R., Suh, E., Thomas, R., Tint, N. N., Tse, S., Vech, C., Wang, G., Wetter, J., Williams, S., Williams, M., Windsor, S., Winn-Deen, E., Wolfe, K., Zaveri, J., Zaveri, K., Abril, J. F., Guigo, R., Campbell, M. J., Sjolander, K. V., Karlak, B., Kejariwal, A., Mi, H., Lazareva, B., Hatton, T., Narechania, A., Diemer, K., Muruganujan, A., Guo, N., Sato, S., Bafna, V., Istrail, S., Lippert, R., Schwartz, R., Walenz, B., Yooseph, S., Allen, D., Basu, A., Baxendale, J., Blick, L., Caminha, M., Carnes-Stine, J., Caulk, P., Chiang, Y. H., Coyne, M., Dahlke, C., Mays, A., Dombroski, M., Donnelly, M., Ely, D., Esparham, S., Fosler, C., Gire, H., Glanowski, S., Glasser, K., Glodek, A., Gorokhov, M., Graham, K., Gropman, B., Harris, M., Heil, J., Henderson, S., Hoover, J., Jennings, D., Jordan, C., Jordan, J., Kasha, J., Kagan, L., Kraft, C., Levitsky, A., Lewis, M., Liu, X., Lopez, J., Ma, D., Majoros, W., McDaniel, J., Murphy, S., Newman, M., Nguyen, T., Nguyen, N., Nodell, M., Pan, S., Peck, J., Peterson, M., Rowe, W., Sanders, R., Scott, J., Simpson, M., Smith, T., Sprague, A., Stockwell, T., Turner, R., Venter, E., Wang, M., Wen, M., Wu, D., Wu, M., Xia, A., Zandieh, A., and Zhu, X. 2001. The sequence of the human genome. Science 291:1304-1351.
4. The Arabidopsis Genome Initiative. 2000. Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408:796-815.
5. Levine, M. and Tjian, R. 2003 Transcription regulation and animal diversity. Nature 424:147-51.
6. Graveley, B. R. 2001. Alternative splicing: increasing diversity in the proteomic world. Trends in Genetics 17:100-107.
7. Mann, M. and Jensen, O. N. 2003. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21:255-261.
8. Van Oostrum, J. and Voshol, H. 2002. The human genome: proteomics. Am. J. Psychiatry 159:208.
9. Anderson, L. and Seilhamer, J. 1997. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537.
10. Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. 1999. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1720-1730.
11. Klose, J., Nock, C., Herrmann, M., Stuhler, K., Marcus, K., Bluggel, M., Krause, E., Schalkwyk, L. C., Rastan, S., Brown, S. D., Bussow, K., Himmelbauer, H., and Lehrach, H. 2002. Genetic analysis of the mouse brain proteome. Nat. Genet. 30:385-393.
12. Hoving, S., Voshol, H., and Van Oostmm, J. 2000. Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis 21:2617-2621.
13. Hoving, S., Gerrits, B., Voshol, H., Müller, D., Roberts, R. C., and Van Oostrum, J. 2002. Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients. Proteomics 2:127-134.
14. Ferguson, P. L. and Smith, R. D. 2003. Proteome analysis by mass spectrometry. Annu. Rev. Biophys. Biomol. Struct. 32:399-124.
15. Griffin, T. J. and Aebersold, R. 2001. Advances in proteome analysis by mass spectrometry. J. Biol. Chem. 276:45497-15500.
16. Phizicky, E., Bastiaens, P. I., Zhu, H., Snyder, M., and Fields, S. 2003 Protein analysis on a proteomic scale. Nature 422:208-215.
17. Aebersold, R. and Mann, M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
18. Andersen, J. S., Lyon, C. E., Fox, A. H, Leung, A. K. L., Lam, Y. W., Steen, H., Mann, M., and Lamond, A. I. 2002. Directed proteomic analysis of the human nucleolus. Current Biology 12: 1-11.
19. Taylor, S. W., Fahy, E., and Ghosh, S. S. 2003. Global organellar proteomics. Trends Biotechnol. 21:82-88.
20. Liu, Y., Patricelli, M. P., and Cravatt, B. F. 1999. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96:14694-14699.
21. Kidd, D., Liu, Y., and Cravatt, B. F. 2001. Profiling serine hydrolase activities in complex proteomes. Biochemistry 40:4005-4015.
22. Unlu, M., Morgan, M. E., and Minden, J. S. 1997. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18:2071-2077.
23. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17: 994-999.
24. Müller, D. R., Schindler, P., Towbin, H., Wirth, U., Voshol, H., Hoving, S., and Steinmetz, M. O. 2001. Isotope-tagged cross-linking reagents. A new tool in mass spectrometric protein interaction analysis. Anal. Chem. 73:1927-1934.
25. Vuong, G. L., Weiss, S. M., Kammer, W., Priemer, M., Vingron, M., Nordheim, A., and Cahill, M. A. 2000. Improved sensitivity proteomics by postharvest alkylation and radioactive labelling of proteins. Electrophoresis 21:2594-2605.
26. Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., and Liotta, L. A. 1996. Laser capture microdissection. Science 274:998-1001.
27. Wright, G. W., Jr., Cazares, L. H., Leung, S. M., Nasim, S., Adam, B. L., Yip, T. T., Schellhammer, P. F., Gong, L., and Vlahou, A. 1999. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 2:264-276.
28. Craven, R. A., Totty, N., Harnden, P., Selby, P. J., and Banks, R. E. 2002. Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am. J. Pathol. 160:815-822.
29. Mouledous, L., Hunt. S., Harcourt, R., Harry, J., Williams, K. L., and Gutstein, H. B. 2003. Navigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples. Proteomics 3:610-615.
30. Kondo, T., Seike, M., Mori, Y., Fujii, K., Yamada, T., and Hirohashi, S. 2003. Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics 3: 1758-1766.
31. Chaurand, P., Schwartz, S. A., and Caprioli, R. M. 2002. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr. Opin. Chem. Biol. 6:676-681.
32. Stoeckli, M., Chaurand, P., Hallahan, D. E., and Caprioli, R. M. 2001. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 7:493-496.
33. Weinberger, S. R., Morris, T. S., and Pawlak, M. 2000. Recent tends in protein biochip technology. Pharmacogenomics 1:395-416.
34. Beher, D., Wrigley, J. D., Owens, A. P., and Shearman, M. S. 2002. Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J. Neurochem. 82: 563-575.
35. Choudhary, J. S., Blackstock, W. P., Creasy, D. M., and Cottrell, J. S. 2001. Interrogating the human genome using uninterpreted mass spectrometry data. Proteomics 1:651-667. Erratum in: Proteomics 2001;1(6):796.
36. Gavin, A. C., Bosche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A. M., Cruciat, C. M., Remor, M., Hofert, C., Schelder, M., Brajenovic, M., Ruffner, H., Merino, A., Klein, K., Hudak, M., Dickson, D., Rudi, T., Gnau, V., Bauch, A., Bastuck, S., Huhse, B., Leutwein, C., Heurtier, M. A., Copley, R. R., Edelmann, A., Querfurth, E., Rybin, V., Drewes, G., Raida, M., Bouwmeester T., Bork, P., Seraphin, B., Kuster, B., Neubauer, G., and Superti-Furga, G. 2002. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415:141-147.
37. Ho, Y., Gruhler, A., Heilbut, A., Bader, G. D., Moore, L., Adams, S. L., Millar, A., Taylor, P., Bennett, K., Boutilier, K., Yang, L., Wolting, C., Donaldson, I., Schandorff, S., Shewnarane, J., Vo, M., Taggart, J., Goudreault, M., Muskat, B., Alfarano, C., Dewar, D., Lin, Z., Michalickova, K., Willems, A. R., Sassi, H., Nielsen, P. A., Rasmussen, K. J., Andersen, J. R., Johansen, L. E., Hansen, L. H., Jespersen, H., Podtelejnikov, A., Nielsen, E., Crawford, J., Poulsen, V., Sorensen, B. D., Matthiesen, J., Hendrickson, R. C., Gleeson, F., Pawson, T., Moran, M. F., Durocher, D., Mann, M., Hogue, C. W., Figeys, D., and Tyers, M. 2002. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415:180-183.
38. Yun, M., Wu, W., Hood, L., and Harrington, M. 1992. Human cerebrospinal fluid protein database. Electrophoresis 13:1012-1013.
39. Johnson, G., Brane, D., van Kammen, D. P., Gurklis, J., Peters, J. L., Perel, J. M., Ghanbari, H. A., and Merril, C. R. 1992. Haloperidol induced CSF protein variations in schizophrenic patients: as studied by two-dimensional electrophoresis. Appl. Theor. Electrophor. 3:21-26.
40. Johnson, G., Brane, D., Block, W., van Kammen, D. P., Gurklis, J., Peters, J. L., Wyatt, R. J., Kirch, D. G., Ghanbari, H. A., and Merril, C. R. 1992. Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia.. Appl. Theor. Electrophor. 3:47-53.
41. Zabel, C., Chamrad, D. C., Priller, J., Woodman, B., Meyer, H. E., Bates, G. P., and Klose, J. 2002. Alterations in the mouse and human proteome caused by Huntington's disease. Mol. Cell. Proteomics 1:366-375.
42. Benes, F. M. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Rev. 31:251-269.
43. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., and Levitt, P. 2001. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6:293-301.
44. Mirnics, K., Middleton, F. A., Lewis, D. A., and Levitt, P. 2001. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24:479-486.
45. Voshol, J., Glucksman, M. J., and van Oostrum, H. 2003. Proteomics in the discovery of new therapeutic targets for psychiatric disease. Current Molecular Medicine 3:446-157.
46. Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M. P., and Sankoorikal, E. B. 2000. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci. 20:8305-8314.
47. Tallerico, T., Novak, G., Liu, I. S., Ulpian, C., and Seeman, P. 2001. Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex. Mol. Brain Res. 87:160-165.
48. Edgar, P. F., Schonberger, S. J., Dean, B., Faull, R. L., Kydd, R., and Cooper, G. J. 1999. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol. Psychiatry 4:173-178.
49. Edgar, P. F., Douglas, J. E., Knight, C., Cooper, G. J., Faull, R. L., and Kydd, R. 1999. Proteome map of the human hippocampus. Hippocampus 9:644-650.
50. Edgar, P. F., Douglas, J. E., Cooper, G. J., Dean, B., Kydd, R., and Faull, R. L. 2000. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry. 5:85-90.
51. Schonberger, S. J., Edgar, P. F., Kydd, R., Faull, R. L., and Cooper, G. J. 2001. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 1:1519-1528.
52. Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., and Levitt, P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
53. Vawter, M. P., Barrett, T., Cheadle, C., Sokolov, B. P., Wood, W. H. 3rd, Donovan, D. M., Webster, M., Freed, W. J., and Becker, K. G. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55: 641-650.
54. Tsai, G. and Coyle, J. T. 2002. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42:165-179.
55. Vissel, B., Royle, G. A., Christie, B. R., Schiffer, H. H., Ghetti, A., Tritto, T., Perez-Otano, I., Radcliffe, R. A., Seamans, J., Sejnowski, T., Wehner, J. M., Collins, A. C., O'Gorman, S., and Heinemann, S. F. 2001. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron 29:217-227.
56. Takuma, H., Kwak, S., Yoshizawa, T., and Kanazawa, I. 1999. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann. Neurol. 46:806-815.
57. Paulson, L., Martin, P., Persson, A., Nilsson, C. L., Ljung, E., Westman-Brinkmalm, A., Eriksson, P. S,, Blennow, K., and Davidsson, P. 2003. Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J. Neurosci. Res. 71: 526-533.
58. Walikonis, R. S., Jensen, O. N., Mann, M., Provance, D. W., Jr., Mercer, J. A., and Kennedy, M. B. 2000. Identification of proteins in the postsynaptic density fraction by mass spectrometry. J. Neurosci. 20:4069-1080.
59. Husi, H., Ward, M. A., Choudhary, J. S, Blackstock, W. P., and Grant, S. G. 2000. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 3:661-669.
60. Evin, G. and Weidemann, A. 2002. Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides. Peptides 23: 1285-1297.
61. Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., and Selkoe, D. J. 2003. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. USA 100:6382-6387.
62. Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Muller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., Wollmer, M. A., Umbricht, D., de Quervain, D. J., Hofmann, M., Maddalena, A., Papassotiropoulos, A., and Nitsch, R. M. 2003. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38:547-554.
63. Marr, R., Rockenstein, E., Mukherjee, A., Kindy, M., Hersh, L., Gage, F., Verma, I., and Masliah, E. 2003. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23:1992-1996.
64. Kawahara, M. and Kuroda, Y. 2000. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 53:389-397.
65. Yip, C. M. and McLaurin, J. 2001. Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 80:1359-1371.
66. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., and Malinow, R. 2003. APP processing and synaptic function. Neuron 37:925-937.
67. Sponne, I., Fifre, A., Drouet, B., Klein, C., Koziel, V., Pincon-Raymond, M., Olivier, J. L., Chambaz, J., and Pillot, T. 2003. Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J. Biol. Chem. 278: 3437-3445.
68. Marques, C. a., Keil, U., Bonert, A., Steiner, B., Haass, C., Muller, W. E., and Eckert, A. 2003. Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J. Biol. Chem. 278:28294-28302.
69. Palop, J. J., Jones, B., Kekonius, L., Chin, J., Yu, G. Q., Raber, J., Masliah, E., and Mucke, L. 2003. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc. Natl. Acad. Sci. USA 100:9572-9577.
70. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-6.
71. Halliwell, B. and Gutteridge, J. M. C. 1999. Free radicals, other reactive species and disease. Pages 617-783, in Free radicals in biology and medicine, Oxford University Press, New York.
72. Pearce, R. K., Owen, A., Daniel, S., Jenner, P., and Marsden, C. D. 1997. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104:661-677.
73. Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., and Halliwell, B. 1997. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1326-9.
74. Floor, E. and Wetzel, M. G. 1998. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70:268-275.
75. Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., and Halliwell, B. 1997. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69:1196-203.
76. Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381-389.
77. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., and Mizuno, Y. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93:2696-2701.
78. Jenner, P. 2003. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 (Suppl) 3:S26-36; discussion S36-38.
79. Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B, Jenner, P., and Marsden, C. D. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:823-827.
80. Cardellach, F., Marti, M. J., Fernandez-Sola, J., Marin, C., Hoek, J. B., Tolosa, E., and Urbano-Marquez, A. 1993. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 43:2258-62.
81. Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., and Shults, C. W. 1995. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol. 37:714-722.
82. Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. P., Parker, W. D., Jr., and Bennett, J. P., Jr. 1997. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362:77-86.
83. Barrientos, A. and Moraes, C. T. 1999. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274:16188-97.
84. Votyakova, T. V. and Reynolds, I. J. 2001. DeltaPsi(m)-dependent and -independent production of reactive oxygen species by rat brain mitochondria. J. Neurochem. 79:266-277.
85. Kushnareva, Y., Murphy, A. N., and Andreyev, A. 2002. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem. J. 368:545-553.
86. Nicklas, W. J., Vyas, I., and Heikkila, R. E. 1985. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36:2503-2508.
87. Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M., and Ischiropoulos, H. 2000. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275:18344-18349.
88. Conway, K. A., Rochet, J. C., Bieganski, R. M., and Lansbury, P. T., Jr. 2001. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346-1349.
89. Norris, E. H., Giasson, B. I., Ischiropoulos, H., and Lee, V. M. 2003. Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J. Biol. Chem. 278:27230-27240.
90. Giasson, B. I. and Lee, V. M. 2003. Are ubiquitination pathways cental to Parkinson's disease? Cell 114:1-8.
91. Dekker, M. C., Bonifati, V., and van Duijn, C. M. 2003. Parkinson's disease: piecing together a genetic jigsaw. Brain 126: 1722-1733.
92. Hastings, T. G. and Berman, S. B. 1999. Dopamine-induced toxicity and quinone modification of proteins: implications for Parkinson's disease. Pages 69-89, in Creveling, C. R. (ed.), Role of catechol quinone species in cellular toxicity, F. P. Graham Publishing Inc, Johnson City, TN.
93. Graham, D. G., Tiffany, S. M., Bell, W. R., Jr., and Gutknecht, W. F. 1978. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:644-653.
94. Hastings, T. G. and Zigmond, M. J. 1994. Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63:1126-1132.
95. Hastings, T. G., Lewis, D. A., and Zigmond, M. J. 1996. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93:1956-1961.
96. Rabinovic, A. D., Lewis, D. A., and Hastings, T. G. 2000. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101:67-76.
97. La Voie, M. J. and Hastings, T. G. 1999. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19:1484-1491.
98. Teismann, P., Tieu, K., Choi, D. K., Wu, D. C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., and Przedborski, S. 2003. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA 100:5473-5478.
99. Spencer, J. P., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., and Halliwell, B. 1998. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71: 2112-2122.
100. Berman, S. B., Zigmond, M. J., and Hastings, T. G. 1996. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67:593-600.
101. Whitehead, R. E., Ferrer, J. V., Javitch, J. A., and Justice, J. B. 2001. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J. Neurochem. 76: 1242-1251.
102. Kuhn, D. M., Arthur, R. E. Jr., Thomas, D. M., and Elferink, L. A. 1999. Tyrosine hydroxylase is inactivated by catecholquinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease. J Neurochem. 73:1309-17.
103. Montine, T. J., Farris, D. B., and Graham, D. G. 1995. Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J. Neuropathol. Exp. Neurol. 54:311-319.
104. Gardner, P. R., Raineri, I., Epstein, L. B., and White, C. W. 1995. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 270:13399-13405.
105. Hayes, J., Tipton, K. F., Bianchi, L., and Corte, L. D. 2001. Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. Brain Res. Bull. 55:239-245.